219 related articles for article (PubMed ID: 27203542)
1. High Incidence of Veno-Occlusive Disease With Myeloablative Chemotherapy Following Craniospinal Irradiation in Children With Newly Diagnosed High-Risk CNS Embryonal Tumors: A Report From the Children's Oncology Group (CCG-99702).
Nazemi KJ; Shen V; Finlay JL; Boyett J; Kocak M; Lafond D; Gardner SL; Packer RJ; Nicholson HS
Pediatr Blood Cancer; 2016 Sep; 63(9):1563-70. PubMed ID: 27203542
[TBL] [Abstract][Full Text] [Related]
2. Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience.
Zaky W; Dhall G; Ji L; Haley K; Allen J; Atlas M; Bertolone S; Cornelius A; Gardner S; Patel R; Pradhan K; Shen V; Thompson S; Torkildson J; Sposto R; Finlay JL
Pediatr Blood Cancer; 2014 Jan; 61(1):95-101. PubMed ID: 23934933
[TBL] [Abstract][Full Text] [Related]
3. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
[TBL] [Abstract][Full Text] [Related]
4. Association Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation.
Bognàr T; Bartelink IH; Egberts TCG; Rademaker CMA; Versluys AB; Slatter MA; Kletzel M; Nath CE; Cuvelier GDE; Savic RM; Dvorak C; Long-Boyle JR; Cowan MJ; Bittencourt H; Bredius RGM; Güngör T; Shaw PJ; Ansari M; Hassan M; Krajinovic M; Hempel G; Marktel S; Chiesa R; Théoret Y; Lund T; Orchard PJ; Wynn RF; Boelens JJ; Lalmohamed A
Transplant Cell Ther; 2022 Apr; 28(4):196-202. PubMed ID: 35065280
[TBL] [Abstract][Full Text] [Related]
5. Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation.
Roeker LE; Kim HT; Glotzbecker B; Nageshwar P; Nikiforow S; Koreth J; Armand P; Cutler C; Alyea EP; Antin JH; Richardson PG; Soiffer RJ; Ho VT
Biol Blood Marrow Transplant; 2019 Jan; 25(1):137-144. PubMed ID: 30081073
[TBL] [Abstract][Full Text] [Related]
6. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL
Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 Study.
Putta S; Young BA; Levine JE; Reshef R; Nakamura R; Strouse C; Perales MA; Howard A; Pine P; Shi J; Zhang P; Ho VT; Saber W
Transplant Cell Ther; 2023 Mar; 29(3):166.e1-166.e10. PubMed ID: 36574581
[TBL] [Abstract][Full Text] [Related]
8. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Shore T; Iacobelli M; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ;
Biol Blood Marrow Transplant; 2017 Jun; 23(6):997-1004. PubMed ID: 28285079
[TBL] [Abstract][Full Text] [Related]
9. Regimen-related toxicity of myeloablative chemotherapy with BCNU, thiotepa, and etoposide followed by autologous stem cell rescue for children with newly diagnosed glioblastoma multiforme: report from the Children's Cancer Group.
Grovas AC; Boyett JM; Lindsley K; Rosenblum M; Yates AJ; Finlay JL
Med Pediatr Oncol; 1999 Aug; 33(2):83-7. PubMed ID: 10398181
[TBL] [Abstract][Full Text] [Related]
10. Pilot Study of Intensive Chemotherapy With Peripheral Hematopoietic Cell Support for Children Less Than 3 Years of Age With Malignant Brain Tumors, the CCG-99703 Phase I/II Study. A Report From the Children's Oncology Group.
Cohen BH; Geyer JR; Miller DC; Curran JG; Zhou T; Holmes E; Ingles SA; Dunkel IJ; Hilden J; Packer RJ; Pollack IF; Gajjar A; Finlay JL;
Pediatr Neurol; 2015 Jul; 53(1):31-46. PubMed ID: 26092413
[TBL] [Abstract][Full Text] [Related]
11. [Treatment outcome of primary central nervous system germ cell tumors after combined therapy: a report of 23 cases].
Yang QY; Sun XF; Huang HQ; Zhen ZJ; Xia Y; Cai QQ; Ling JY
Ai Zheng; 2008 Apr; 27(4):438-41. PubMed ID: 18423134
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.
Rosenthal J; Sender L; Secola R; Killen R; Millerick M; Murphy L; Cairo MS
Bone Marrow Transplant; 1996 Jul; 18(1):185-91. PubMed ID: 8832013
[TBL] [Abstract][Full Text] [Related]
13. Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Risk Factors and Stratification, Prophylaxis, and Treatment.
Dalle JH; Giralt SA
Biol Blood Marrow Transplant; 2016 Mar; 22(3):400-9. PubMed ID: 26431626
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes and late toxicities in patients with embryonal central nervous system tumors.
Odagiri K; Omura M; Hata M; Aida N; Niwa T; Goto H; Ito S; Adachi M; Yoshida H; Yuki H; Inoue T
Radiat Oncol; 2014 Sep; 9():201. PubMed ID: 25209395
[TBL] [Abstract][Full Text] [Related]
15. Phase II Trial of Response-Based Radiation Therapy for Patients With Localized CNS Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study.
Fangusaro J; Wu S; MacDonald S; Murphy E; Shaw D; Bartels U; Khatua S; Souweidane M; Lu HM; Morris D; Panigrahy A; Onar-Thomas A; Fouladi M; Gajjar A; Dhall G
J Clin Oncol; 2019 Dec; 37(34):3283-3290. PubMed ID: 31545689
[TBL] [Abstract][Full Text] [Related]
16. Higher Cryopreserved CD34
Kato S; Konuma T; Monna-Oiwa M; Isobe M; Takahashi S; Nannya Y
Transplant Cell Ther; 2022 Nov; 28(11):779.e1-779.e9. PubMed ID: 35995391
[TBL] [Abstract][Full Text] [Related]
17. Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue.
Grodman H; Wolfe L; Kretschmar C
Pediatr Blood Cancer; 2009 Jul; 53(1):33-6. PubMed ID: 19326417
[TBL] [Abstract][Full Text] [Related]
18. Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children.
Kellie SJ; Wong CK; Pozza LD; Waters KD; Lockwood L; Mauger DC; White L
Med Pediatr Oncol; 2002 Sep; 39(3):168-74. PubMed ID: 12210445
[TBL] [Abstract][Full Text] [Related]
19. Manifestations and management of veno-occlusive disease/sinusoidal obstruction syndrome in the era of contemporary therapies.
Tewari P; Wallis W; Kebriaei P
Clin Adv Hematol Oncol; 2017 Feb; 15(2):130-139. PubMed ID: 28398284
[TBL] [Abstract][Full Text] [Related]
20. Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: Final Results From the International Compassionate-Use Program.
Corbacioglu S; Carreras E; Mohty M; Pagliuca A; Boelens JJ; Damaj G; Iacobelli M; Niederwieser D; Olavarría E; Suarez F; Ruutu T; Verdonck L; Hume R; Nejadnik B; Lai C; Finetto G; Richardson P
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1874-1882. PubMed ID: 27397724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
